Format

Send to

Choose Destination
Clin Perinatol. 2015 Mar;42(1):47-59, viii. doi: 10.1016/j.clp.2014.10.005. Epub 2014 Dec 4.

Neonatal herpes simplex virus infection: epidemiology and treatment.

Author information

1
University of Alabama at Birmingham, Children's Harbor Building 308, 1600 7th Avenue South, Birmingham, AL 35233-1711, USA.
2
Department of Pediatrics, University of Alabama at Birmingham, Children's Harbor Building 303, 1600 7th Avenue South, Birmingham, AL 35233-1711, USA. Electronic address: dkimberlin@peds.uab.edu.

Abstract

Herpes simplex virus types 1 (HSV-1) and 2 (HSV-2) are highly prevalent viruses capable of establishing lifelong infection. Genital herpes in women of childbearing age represents a major risk for mother-to-child transmission (MTCT) of HSV infection, with primary and first-episode genital HSV infections posing the highest risk. The advent of antiviral therapy with parenteral acyclovir has led to significant improvement in neonatal HSV disease mortality. Further studies are needed to improve the clinician's ability to identify infants at increased risk for HSV infection and prevent MTCT, and to develop novel antiviral agents with increased efficacy in infants with HSV infection.

KEYWORDS:

Antiviral therapy; Genital herpes; Herpes simplex virus; Mother-to-child transmission; Neonatal herpes; Polymerase chain reaction; Pregnancy

PMID:
25677996
DOI:
10.1016/j.clp.2014.10.005
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Elsevier Science
Loading ...
Support Center